The infant formula maker has manged to ride out the harsh zero-COVID lockdowns imposed on its most lucrative market, but investors are not impressed.
Business / Companies
Brisbane Times – Business
The infant formula maker has manged to ride out the harsh zero-COVID lockdowns imposed on its most lucrative market, but investors are not impressed.
Business / Companies
Brisbane Times – Business